secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001628280-23-009312
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Oncology Institute issues FY2022 results and 2023 guidance; specific numbers not available in filing text
--------------------------------------------------------------------------------

- Slide presentation furnished as Exhibit 99.1 includes financial results for Q4 and FY2022.
- Presentation also provides business update and guidance for the year ending December 31, 2023.
- Exact revenue, EPS, or other financial figures are not disclosed in the provided filing excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000162828023009312/0001628280-23-009312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000162828023009312/toi-20230327.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-009312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer